Linked Life Data

12598856

Source:http://linkedlifedata.com/resource/pubmed/id/12598856

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2003-2-24
pubmed:abstractText
Intense immunosuppression plus stem-cell transplantation (SCT) has emerged as a new treatment modality for patients with refractory, severe rheumatic autoimmune disease. Its rationale is based on eliminating autoaggressive lymphocytes by lympho- or myeloablative conditioning followed by stem-cell rescue. Preclinical studies in animal models of autoimmune disease and observations in patients with rheumatoid arthritis (RA) who were cured after allogeneic bone marrow transplantation for concomitant hematologic malignancy have provided support for the concept.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
1073-2748
pubmed:author
pubmed:issnType
Print
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
57-65
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:articleTitle
Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: a review.
pubmed:affiliation
Department of Rheumatology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands. j.m.van_laar@lumc.nl
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't